Is percutaneous heart valve replacement a feasible option for inoperable aortic stenosis?
Rebecca Ireland
This article has no abstract so we have provided the first paragraph of the full text.
Surgical valve replacement is currently the only effective treatment for patients with aortic stenosis. Many patients are, however, unsuitable for surgery because of end-stage disease, older age and multiple comorbidities. The first successful human percutaneous aortic heart valve (PHV) implantation was performed in 2002. Cribier et al. have assessed the feasibility and safety of this procedure in patients with end-stage aortic stenosis and multiple comorbidities.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
